Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2022-02-10 | 2022-05-19 | 154723 |
TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2022-02-17 | 2022-03-24 | 155152 |
TEVA-FLUOXETINE | 10MG | CAPSULE | Resolved | 2022-02-17 | 2022-02-17 | 155162 |
OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT | Resolved | 2022-03-04 | 2022-03-24 | 156070 |
TEVA-TAMOXIFEN | 10MG | TABLET | Resolved | 2022-03-24 | 2022-12-02 | 157256 |
ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-03-31 | 2022-06-17 | 157637 |
TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2022-04-28 | 2022-12-22 | 159593 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2022-04-28 | 2022-05-06 | 159596 |
TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2022-05-19 | 2022-08-09 | 161006 |
TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2022-06-03 | 2023-04-28 | 161952 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2022-06-09 | 2022-07-26 | 162291 |
TEVA-TAMOXIFEN | 10MG | TABLET | Resolved | 2022-06-09 | 2022-11-12 | 162306 |
TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2022-06-30 | 2022-08-16 | 163903 |
TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163927 |
TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-06-30 | 2023-04-28 | 163942 |
OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-06-13 | 166969 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-08-18 | 2022-10-18 | 167153 |
TEVA-HALOPERIDOL | 10MG | TABLET | Resolved | 2022-08-18 | 2023-06-09 | 167171 |
TEVA-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2022-08-18 | 2022-10-01 | 167188 |
TEVA-SIMVASTATIN | 10MG | TABLET | Resolved | 2022-09-07 | 2023-06-21 | 168749 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |